Evolution of drug-eluting biomedical implants for sustained drug delivery.
Quarterman JC, Geary SM, Salem AK.
Eur J Pharm Biopharm. 2021 Feb;159:21-35. doi: 10.1016/j.ejpb.2020.12.005. Epub 2020 Dec 16.
State-of-the-art methods in clinical intracochlear drug delivery.
Chin OY, Diaz RC.
Curr Opin Otolaryngol Head Neck Surg. 2019 Oct;27(5):381-386. doi: 10.1097/MOO.0000000000000566.
Mathematical modelling of the drug release from an ensemble of coated pellets.
Caccavo D, Lamberti G, Cafaro MM, Barba AA, Kazlauske J, Larsson A.
Br J Pharmacol. 2017 Jun;174(12):1797-1809. doi: 10.1111/bph.13776. Epub 2017 Apr 22.
The role of intracochlear drug delivery devices in the management of inner ear disease.
Ayoob AM, Borenstein JT.
Expert Opin Drug Deliv. 2015 Mar;12(3):465-79. doi: 10.1517/17425247.2015.974548. Epub 2014 Oct 27.
Recent Advances in Polymeric Implants.
Ahmed KK, Tamer MA, Ghareeb MM, Salem AK.
AAPS PharmSciTech. 2019 Sep 3;20(7):300. doi: 10.1208/s12249-019-1510-0.
Premenstrual syndrome.
Kwan I, Onwude JL.
BMJ Clin Evid. 2015 Aug 25;2015:0806.
Design of a Drug-Eluting Subcutaneous Implant of the Antiretroviral Tenofovir Alafenamide Fumarate.
Simpson SM, Widanapathirana L, Su JT, Sung S, Watrous D, Qiu J, Pearson E, Evanoff A, Karunakaran D, Chacon JE, Kiser PF.
Pharm Res. 2020 Apr 15;37(4):83. doi: 10.1007/s11095-020-2777-2.
Evolution of implantable and insertable drug delivery systems.
Kleiner LW, Wright JC, Wang Y.
J Control Release. 2014 May 10;181:1-10. doi: 10.1016/j.jconrel.2014.02.006. Epub 2014 Feb 15.
Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres.
Menei P, Benoit JP, Boisdron-Celle M, Fournier D, Mercier P, Guy G.
Neurosurgery. 1994 Jun;34(6):1058-64; discussion 1064. doi: 10.1227/00006123-199406000-00016.
Synthetic biodegradable polyesters for implantable controlled-release devices.
Pothupitiya JU, Zheng C, Saltzman WM.
Expert Opin Drug Deliv. 2022 Oct;19(10):1351-1364. doi: 10.1080/17425247.2022.2131768. Epub 2022 Oct 25.
